Pacira Biosciences Announces Settlement Of U.S. Patent Litigation For Exparel
Reuters
04-08
April 7 (Reuters) - Pacira Biosciences Inc :: *PACIRA BIOSCIENCES ANNOUNCES SETTLEMENT OF U.S. PATENT LITIGATION FOR EXPAREL *PACIRA BIOSCIENCES INC - FRESENIUS KABI LICENSED TO SELL GENERIC BUPIVACAINE IN U.S. FROM 2030 *PACIRA BIOSCIENCES INC - FRESENIUS TO SELL GENERIC BUPIVACAINE WITHOUT LIMITATIONS FROM 2039